PNC Financial Services Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
GL
B
1WCM
VCM
TC
MAM
PNC Financial Services Group's MRVI Position: Q1 2026 in Review
PNC Financial Services Group increased its Maravai LifeSciences (MRVI) stake by 0.28% in Q1 2026, buying an estimated $119 and bringing the position to 12,521 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3420.
PNC Financial Services Group first reported a position in MRVI in Q2 2021 and has held it in 20 quarters since. The position peaked at $124K in Q1 2023. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.
- PNC Financial Services Group held 12,521 shares of Maravai LifeSciences worth $35.4K as of Q1 2026.
- PNC Financial Services Group bought 35 Maravai LifeSciences shares in Q1 2026, an estimated $119.
- Maravai LifeSciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3420 holding.
- PNC Financial Services Group first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 20 quarters since.
- PNC Financial Services Group's Maravai LifeSciences position peaked at $124K in Q1 2023.
- 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.